BiotechTube
Home/Lundbeck/Charl van Zyl
CV

Charl van Zyl

Executive Vice President, Head of Europe & International Markets

Lundbeck

Therapeutic Areas

PsychiatryNeurologyNeuro-rare Diseases

Lundbeck Pipeline

DrugIndicationPhase
Lu AG09222 (mAb)Migraine PreventionPhase 2
Lu AG06466Parkinson's Disease PsychosisPhase 2
Lu AG13909SchizophreniaPhase 1
Lu AG09222Post-Traumatic Stress Disorder (PTSD)Phase 2

Leadership Team at Lundbeck

TG
Thomas Gibbs
Executive Vice President and President, Lundbeck North America
JL
Johan Luthman
Executive Vice President, Head of Research & Development
View full Lundbeck profile